The supplementation of a whey-derived peptide has been shown to lower self-perceived levels of stress among middle-aged ...
“Unlike traditional Parkinson’s treatments that aim to restore dopamine levels, solengepras is designed to selectively target and modulate the specific brain circuits responsible for controlling ...
Senior author Joaquim Alves da Silva, head of the Neural Circuits Dysfunction Lab, said, "This is the first large study to ...
From an evolutionary standpoint, dopamine rewards you when you’re doing things necessary for survival, such as eating and ...
Oct. 4, 2024 — A research team has revealed that a molecule in the brain -- ophthalmic acid -- unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function ...
Understanding how human neurons cope with the energy demands of a large, active brain could open up new avenues for treating ...
The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the ...
The Food and Drug Administration (FDA) has granted accelerated approval to Kebilidiâ„¢ (eladocagene exuparvovec-tneq) for the treatment of adult and pediatric patients with aromatic L-amino acid ...
PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
The approval marks the first time gene therapy will be available to treat patients with aromatic I-amino acid decarboxylase ...